Literature DB >> 9398805

Prediction of effect of interferon on chronic hepatitis C.

H Takagi1, K Takehara, R Shimoda, S Kakizaki, H Takayama, T Abe, T Yamada, Y Hashimoto, S Saitoh, T Matsumoto, A Kojima, J Takezawa, K Yuasa, M Moriguchi, T Sekiguchi, T Nagamine, M Mori.   

Abstract

Clinical, pathological, and virological analysis including hypervariable region-1 of hepatitis C virus (HCV) was performed to predict the effect of interferon (IFN) on 41 patients with chronic hepatitis type C. The low virus load, low frequency of the mutation in the hypervariable region-1 as the change of amino acid and high level of serum aminotransferase make one estimate the good effect of IFN on patients with HCV. Mutation in the hypervariable region-1 of HCV measured by fast assay fluorescence single-stranded conformational polymorphism was more frequent in nonresponders to IFN than responders. The most frequently mutated position was amino acid number 406. This indicates that the specific mutation site might affect the response of IFN.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398805     DOI: 10.1023/a:1018866717753

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

Authors:  T Hultman; S Ståhl; E Hornes; M Uhlén
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.

Authors:  M Shindo; K Hamada; S Koya; K Arai; Y Sokawa; T Okuno
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

3.  Interferon therapy for hepatitis C.

Authors:  H Preston; T L Wright
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain.

Authors:  K E Sherman; C Andreatta; J O'Brien; A Gutierrez; R Harris
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

6.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; Y Ogura; N Izumi; F Marumo; C Sato
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

7.  Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.

Authors:  H Sekiya; N Kato; Y Ootsuyama; T Nakazawa; K Yamauchi; K Shimotohno
Journal:  Int J Cancer       Date:  1994-06-01       Impact factor: 7.396

8.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

Authors:  A J Weiner; H M Geysen; C Christopherson; J E Hall; T J Mason; G Saracco; F Bonino; K Crawford; C D Marion; K A Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.

Authors:  A Zibert; E Schreier; M Roggendorf
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  1 in total

1.  Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype.

Authors:  I Nakano; Y Fukuda; Y Katano; H Toyoda; K Hayashi; T Hayakawa; T Kumada; S Nakano
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.